168 related articles for article (PubMed ID: 16640279)
1. Development and validation of a new high-performance liquid chromatography method for the determination of gliclazide and repaglinide in pharmaceutical formulations.
Berecka A; Gumieniczek A; Hopkała H
J AOAC Int; 2006; 89(2):319-25. PubMed ID: 16640279
[TBL] [Abstract][Full Text] [Related]
2. Determination of repaglinide in pharmaceutical formulations by HPLC with UV detection.
Gandhimathi M; Ravi TK; Renu SK
Anal Sci; 2003 Dec; 19(12):1675-7. PubMed ID: 14696936
[TBL] [Abstract][Full Text] [Related]
3. A comparative study of first-derivative spectrophotometry and column high-performance liquid chromatography applied to the determination of repaglinide in tablets and for dissolution testing.
AlKhalidi BA; Shtaiwi M; AlKhatib HS; Mohammad M; Bustanji Y
J AOAC Int; 2008; 91(3):530-5. PubMed ID: 18567297
[TBL] [Abstract][Full Text] [Related]
4. Development of a RP-HPLC method for screening potentially counterfeit anti-diabetic drugs.
Yao J; Shi YQ; Li ZR; Jin SH
J Chromatogr B Analyt Technol Biomed Life Sci; 2007 Jun; 853(1-2):254-9. PubMed ID: 17409031
[TBL] [Abstract][Full Text] [Related]
5. Simultaneous estimation of six anti-diabetic drugs--glibenclamide, gliclazide, glipizide, pioglitazone, repaglinide and rosiglitazone: development of a novel HPLC method for use in the analysis of pharmaceutical formulations and its application to human plasma assay.
Venkatesh P; Harisudhan T; Choudhury H; Mullangi R; Srinivas NR
Biomed Chromatogr; 2006 Oct; 20(10):1043-8. PubMed ID: 16506282
[TBL] [Abstract][Full Text] [Related]
6. Method development and validation of repaglinide in human plasma by HPLC and its application in pharmacokinetic studies.
Ruzilawati AB; Wahab MS; Imran A; Ismail Z; Gan SH
J Pharm Biomed Anal; 2007 Apr; 43(5):1831-5. PubMed ID: 17240100
[TBL] [Abstract][Full Text] [Related]
7. Development and validation of a new analytical HPLC method for simultaneous determination of the antidiabetic drugs, metformin and gliclazide.
Gedawy A; Al-Salami H; Dass CR
J Food Drug Anal; 2019 Jan; 27(1):315-322. PubMed ID: 30648585
[TBL] [Abstract][Full Text] [Related]
8. Simultaneous Determination of Metformin, Glipizide, Repaglinide, and Glimepiride or Metformin and Pioglitazone by a Validated LC Method: Application in the Presence of Metformin Impurity (1-Cyanoguanidine).
El-Zaher AA; Elkady EF; Elwy HM; Saleh MA
J AOAC Int; 2016 Jul; 99(4):957-963. PubMed ID: 27214744
[TBL] [Abstract][Full Text] [Related]
9. ION-pair liquid chromatography technique for the estimation of metformin in its multicomponent dosage forms.
Vasudevan M; Ravi J; Ravisankar S; Suresh B
J Pharm Biomed Anal; 2001 Apr; 25(1):77-84. PubMed ID: 11274860
[TBL] [Abstract][Full Text] [Related]
10. Liquid chromatographic determination of cetirizine in oral formulations.
Bajerski L; Cardoso SG; Diefenbach IF; Malesuik MD; Sílvia H; Borgmann M
J AOAC Int; 2005; 88(2):424-7. PubMed ID: 15859066
[TBL] [Abstract][Full Text] [Related]
11. Spectrofluorimetric and spectrophotometric determination of gliclazide in pharmaceuticals by derivatization with 4-chloro-7-nitrobenzo-2-oxa-1,3-diazole.
El-Enany N
J AOAC Int; 2003; 86(2):209-14. PubMed ID: 12723907
[TBL] [Abstract][Full Text] [Related]
12. Development and validation of a HPLC method for the determination of cetirizine in pharmaceutical dosage forms.
Paw B; Misztal G; Hopkała H; Drozd J
Pharmazie; 2002 May; 57(5):313-5. PubMed ID: 12061254
[TBL] [Abstract][Full Text] [Related]
13. Stability-indicating reversed-phase liquid chromatographic methods for the determination of aconitine and piperine in a polyherbal formulation.
Rai P; Pathak A; Rajput SJ
J AOAC Int; 2009; 92(4):1044-54. PubMed ID: 19714970
[TBL] [Abstract][Full Text] [Related]
14. Development and validation of RP-HPLC method for the analysis of metformin.
Arayne MS; Sultana N; Zuberi MH
Pak J Pharm Sci; 2006 Jul; 19(3):231-5. PubMed ID: 16935831
[TBL] [Abstract][Full Text] [Related]
15. Liquid chromatography--mass spectrometry method for the determination of gliclazide in human plasma and application to a pharmacokinetic study of gliclazide sustained release tablets.
Wang CY; Zhang W; Xiang BR; Yu LY; Ma PC
Arzneimittelforschung; 2008; 58(12):653-8. PubMed ID: 19202737
[TBL] [Abstract][Full Text] [Related]
16. Comparison of UV spectrophotometry and high performance liquid chromatography methods for the determination of repaglinide in tablets.
Dhole SM; Khedekar PB; Amnerkar ND
Pharm Methods; 2012 Jul; 3(2):68-72. PubMed ID: 23781481
[TBL] [Abstract][Full Text] [Related]
17. Electrochemical determination of the antidiabetic drug repaglinide.
El-Ries MA; Mohamed GG; Attia AK
Yakugaku Zasshi; 2008 Jan; 128(1):171-7. PubMed ID: 18176070
[TBL] [Abstract][Full Text] [Related]
18. Determination of gliclazide in pharmaceutical preparations by capillary gas chromatography with cool on-column injection and elimination of the matrix effect.
Krzek J; Czekaj J; Moniczewska M; Rzeszutko W
J AOAC Int; 2001; 84(6):1695-702. PubMed ID: 11767133
[TBL] [Abstract][Full Text] [Related]
19. A simple and sensitive HPLC method for determination of gliclazide in human serum.
Rouini MR; Mohajer A; Tahami MH
J Chromatogr B Analyt Technol Biomed Life Sci; 2003 Mar; 785(2):383-6. PubMed ID: 12554153
[TBL] [Abstract][Full Text] [Related]
20. Application of monolithic column in quantification of gliclazide in human plasma by liquid chromatography.
Foroutan SM; Zarghi A; Shafaati A; Khoddam A
J Pharm Biomed Anal; 2006 Oct; 42(4):513-6. PubMed ID: 16797910
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]